137 related articles for article (PubMed ID: 10989467)
1. Granulocyte-macrophage colony-stimulating factor in the treatment of neonates with neutropenia and sepsis.
Venkateswaran L; Wilimas JA; Dancy R; Wang WC; Korones S; Hayden J; Hayes FA
Pediatr Hematol Oncol; 2000 Sep; 17(6):469-73. PubMed ID: 10989467
[TBL] [Abstract][Full Text] [Related]
2. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human granulocyte colony-stimulating factor in preterm neonates with sepsis and relative neutropenia: a randomized, single-blind, non-placebo-controlled trial.
Gathwala G; Walia M; Bala H; Singh S
J Trop Pediatr; 2012 Feb; 58(1):12-8. PubMed ID: 21296862
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
[TBL] [Abstract][Full Text] [Related]
6. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony-stimulating factor.
Roberts RL; Szelc CM; Scates SM; Boyd MT; Soderstrom KM; Davis MW; Glaspy JA
Am J Dis Child; 1991 Jul; 145(7):808-12. PubMed ID: 1711773
[TBL] [Abstract][Full Text] [Related]
7. Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.
Castagnola E; Dufour C
Early Hum Dev; 2014 Sep; 90 Suppl 2():S15-7. PubMed ID: 25220119
[TBL] [Abstract][Full Text] [Related]
8. [First experience with the use of granulocyte-macrophage colony stimulating factor in pediatric oncology].
Ferencz T; Csáki C; Koós R; Schuler D; Borsi J
Orv Hetil; 1993 Jul; 134(27):1469-73. PubMed ID: 8351131
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
10. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates.
Ahmad M; Fleit HB; Golightly MG; La Gamma EF
Biol Neonate; 2004; 86(1):48-54. PubMed ID: 15057022
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.
Bilgin K; Yaramiş A; Haspolat K; Taş MA; Günbey S; Derman O
Pediatrics; 2001 Jan; 107(1):36-41. PubMed ID: 11134431
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery.
Bailie KE; Irvine AE; Bridges JM; McClure BG
Pediatr Res; 1994 Feb; 35(2):164-8. PubMed ID: 7513077
[TBL] [Abstract][Full Text] [Related]
13. In vivo effect of recombinant human granulocyte colony-stimulating factor on neutrophilic expression of CD11b in septic neonates: a randomized controlled trial.
El-Ganzoury MM; El-Farrash RA; Saad AA; Mohamed AG; El-Sherbini IG
Pediatr Hematol Oncol; 2012 Apr; 29(3):272-84. PubMed ID: 22475305
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial.
Carr R; Brocklehurst P; Doré CJ; Modi N
Lancet; 2009 Jan; 373(9659):226-33. PubMed ID: 19150703
[TBL] [Abstract][Full Text] [Related]
15. Low blood neutrophil concentrations among extremely low birth weight neonates: data from a multihospital health-care system.
Christensen RD; Henry E; Wiedmeier SE; Stoddard RA; Lambert DK
J Perinatol; 2006 Nov; 26(11):682-7. PubMed ID: 17036034
[TBL] [Abstract][Full Text] [Related]
16. [Granulocyte colony-stimulating factor in the newborn neutropenic patient].
Castillo Salinas F; Díaz de Heredia Rubio C; Salcedo Abizanda S; Ferrer Comalat A; Bastida Vila P; Ortega Aramburu JJ; Peguero Monforte G
An Esp Pediatr; 1998 Dec; 49(6):615-8. PubMed ID: 9972625
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
Oza A; Hallemeier C; Goodnough L; Khoury H; Shenoy S; Devine S; Augustin K; Vij R; Trinkaus K; Dipersio JF; Adkins D
Transfusion; 2006 Jan; 46(1):14-23. PubMed ID: 16398726
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
[TBL] [Abstract][Full Text] [Related]
19. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
20. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
Kocherlakota P; La Gamma EF
Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
